Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

Market: Pharmaceuticals and Healthcare

Global, 140 pages report, published by GBI Research

Report ThumbnailMay-2017
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

Summary

Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead to various types of chronic pain and mobility loss, and have a negative

Read More
  • 1.2 List of Figures
  • Figure 1: Immunology, Global, Epidemiology Patterns for Rheumatoid Arthritis (‘000), 2016–2023 22
  • Figure 2: Immunology, Global, Epidemiology Patterns for Systemic Lupus Erythematosus (‘000), 2016–2023 23
  • Figure 3: Immunology, Global, Epidemiology Patterns for Psoriasis (‘000), 2016–2023 24
  • Figure 4: Immunology, Global, Epidemiology Patterns for Inflammatory Bowel Disease (‘000), 2016–2023 25
  • Figure 5: Immunology, Global, Key Marketed Products and Approved Indications, 2016 34
Read More
  • 1.1 List of Tables
  • Table 1: Immunology Therapeutics Market, Symptoms of RA, SLE, Psoriasis and IBD 14
  • Table 2: Immunology Therapeutics Market, Etiology of RA, SLE, Psoriasis and IBD 16
  • Table 3: Immunology, Global, Epidemiology of Inflammatory Immunological Disorders, 2017 22
  • Table 4: Immunology Therapeutics Market, Global, Approved Indications for Humira, 2017 35
  • Table 5: Immunology Therapeutics Market, Global, Approved Indications for Enbrel, 2017 37
  • Table 6: Immunology Therapeutics Market, Glo
Read More
  • 1 Table of Contents
  • 1 Table of Contents 4
  • 1.1 List of Tables 6
  • 1.2 List of Figures 6
  • 2 Introduction 9
  • 2.1 Therapy Area Introduction 9
  • 2.1.1 Rheumatoid Arthritis 9
  • 2.1.2 Systemic Lupus Erythematosus 10
  • 2.1.3 Psoriasis 11
  • 2.1.4 Inflammatory Bowel Disease 12
  • 2.2 Symptoms 13
  • 2.3 Etiology and Pathophysiology 15
  • 2.3.1 Pathophysiology 17
  • 2.4 Epidemiology 21
  • 2.4.1 Rheumatoid Arthritis 22
  • 2.4.2 Systemic Lupus Erythematosus 23
  • 2.4.3 Psoriasis 23
  • 2.4.4 Inflammatory Bowel Disease 24
  • 2.5 Co-morbidities and C
Read More

Related Products

GBI ResearchGlobal Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive GrowthProduct ThumbnailGlobal Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth, Industry ReportProduct #: 820252
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved